Gabrys Christina 4
4 · SYNCHRONOSS TECHNOLOGIES INC · Filed Sep 6, 2024
Insider Transaction Report
Form 4
Gabrys Christina
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2024-09-05$14.27/sh−4,842$69,095→ 41,517 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-05$10.71/sh−4,842$51,858→ 2,421 totalExercise: $10.71From: 2023-07-08Exp: 2029-07-08→ Common Stock (4,842 underlying) - Exercise/Conversion
Common Stock
2024-09-05$10.71/sh+4,842$51,858→ 46,359 total
Footnotes (2)
- [F1]Tax planning for the year given significant stock awards year to date.
- [F2]This grant has a graded vesting schedule, so date exercisable varies for each vesting tranche - 2,421 became exercisable on July 8, 2023 and 2,421 became exercisable on April 26, 2024.